Dômes Pharma, an independent family-owned group, a pioneer in animal health, has been developing, manufacturing, and marketing solutions for the health and well-being of pets since 1947. Established in Auvergne in central France, the region of volcanoes and its domes from which it takes its name, in 2016 the Group began its international expansion by opening subsidiaries in the UK, Germany, Spain and the USA.  In July 2023, the Group acquired the American company Sentrx Animal Care based in Salt Lake City (Utah), which develops and manufactures ophthalmology products, based on an exclusive patented technology that potentiates the action of Hyaluronic acid on the eye of animals. With this acquisition, Dômes Pharma strengthens its world leadership in veterinary ophthalmology while creating a launch pad for its range of therapeutic specialties in North America.

Oculenis XL | Product Detailer

Manufactured in the U.S., OraStripdx is the premier product developed and produced by PDX BIOTECH, a growth-stage biotechnology company based in Louisville, Kentucky. Periodontal disease is an invisible infection that causes needless suffering for millions of dogs and cats. OraStripdx is a revolutionary rapid test that can detect active periodontal disease in dogs and cats in ten seconds, with no anesthesia or sedation required.

Product Detailer | Periodontal Disease Education | Overview Video

KeraVet® Gel is the flagship product of KeraVet Bio, biotechnology company that specializes in keratin technology for veterinary medicine, based in Winston-Salem, NC.

KeraVet Gel is a prescription wound care product indicated for dogs and cats. KeraVet Gel is a topical hydrogel containing patent-protected keratin technology and an effective bitterant. Together this unique combination supports better, faster healing and reduces self-harming behavior. Clinical studies and use cases are available at keravetbio.com. 

KeraVet Gel Detailer | Veterinary Team Fact Sheet

Contura Vet, the animal health division of Contura International in Denmark, was established over 10 years ago with the development of Arthramid® Vet, a 2.5% injectable polyacrylamide (iPAAG) hydrogel used to treat non-infectious causes of joint lameness in animals, including early synovitis through late stages of osteoarthritis and degenerative joint disease in horses. 

ArthramidVet Overview | Technical Summary

Johnson & Johnson MedTech has been serving the surgical and orthopedic needs of veterinary customers and patients for many years. Our vision is to increase access to surgical innovation and solutions within the veterinary community with Ethicon sutures and hemostatic agents.

Fill out this form for a sample and return to animalhealth@its.jnj.com

Plus Suture Overview | Stratafix Overview | Wound Closure Needles | Signature Veterinary Codes | Wound Closure Manual

Absorbable and Non Absorbale Suture Chart | Wound Closure Porfolio

4CYTE™ is part of Interpath Global which is a family-owned company pioneering research and development in the fields of human and animal joint health. They are committed to pushing boundaries via ongoing scientific exploration, to create innovative and unique products that drive change in the industry, and offer natural, effective solutions to those living with joint health problems.

Research Summary | Pre and Post Surgery Care | 4CYTE™ Epiitalis® Forte horse | 4CYTE™ Epiitalis® Forte dog

Research Paper led by Dr. Wayne McIlwraith at CSU

Get in touch with us and learn how we can support your vision.